Vitiligo in a Patient Treated with Interferon Alpha-2a for Behcet's Disease

被引：4

作者：

Guney, Esra ^{[1
]}

Akcali, Gulunay ^{[1
]}

Akcay, Betul Ilkay ^{[1
]}

Unlu, Cihan ^{[1
]}

Erdogan, Gurkan ^{[1
]}

Bozkurt, Tahir Kansu ^{[1
]}

Bayramlar, Huseyin ^{[1
]}

机构：

[1] Umraniye Res & Educ Hosp, Ophthalmol Clin, Istanbul, Turkey

来源：

CASE REPORTS IN MEDICINE | 2012年 / 2012卷

关键词：

D O I：

10.1155/2012/387140

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Behcet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behcet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity. The association between IFN therapy and vitiligo has been reported in the literature. We report a 21-year-old man with BD in whom vitiligo occurred during IFN treatment. To the best of our knowledge, this is the first reported case of such an association.

引用

页数：3

共 50 条

[21] EXPERIENCE WITH INTRAPERITONEAL ALPHA-2A INTERFERON
NICOLETTO, MO
FIORENTINO, MV
VINANTE, O
PROSPERI, A
TREDESE, F
TUMOLO, S
CIMA, GP
MONFARDINI, S
ONCOLOGY, 1992, 49 (06) : 467 - 473
[22] Alpha-2a interferon therapy and pregnancy in a patient with chronic hepatitis C
Masbou, J
Larrey, D
Michel, H
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1995, 19 (11): : 961 - 962
[23] Interferon-alpha in the management of patients with Behcet's disease
Yang, David S. F.
Taylor, Simon R. J.
Lightman, Sue L.
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (10) : 575 - +
[24] Interferon alpha-2A therapy for keloids
S. N. Kesim
I. Buyukcayir
M. Çelik
European Journal of Plastic Surgery, 1997, 20 : 282 - 283
[25] Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a
Celiker, Hande
Kazokoglu, Haluk
Direskeneli, Haner
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (01) : 58 - 65
[26] A Case of Chronic Neutrophilic Leukemia Successfully Treated with Pegylated Interferon Alpha-2a
Yassin, Mohamed A.
Kohla, Samah
Al-Sabbagh, Ahmad
Soliman, Ashraf T.
Yousif, Anil
Moustafa, Afraa
Al Battah, Afaf
Nashwan, Abdulqadir
Al-Dewik, Nader
CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2015, 8 : 33 - 36
[27] LOW-DOSE INTERFERON ALPHA-2A TREATMENT IN REFRACTORY BEHCET UVEITIS: A SINGLE CENTER EXPERIENCE
Yilmaz, S. G.
Keser, G.
Yilmaz, Z.
Aksu, K.
Ates, H.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 927 - 927
[28] Interferon alpha-2a treatment for serpiginous choroiditis
Sobaci, G
Bayraktar, Z
Bayer, A
OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (01) : 59 - 66
[29] Influence of interferon-alpha on lymphocyte subpopulations in Behcet's disease
Treusch, M
Stübiger, N
Vonthein, R
Baur, M
Koch, S
Günaydin, I
Kanz, L
Zierhut, M
Kötter, I
ADAMANTIADES-BEHCET'S DISEASE, 2003, 528 : 533 - 535
[30] Beneficial effects of interferon-alpha in a case with Behcet's disease
Aoki, T
Tanaka, T
Akifuji, Y
Ueki, J
Nakamura, I
Nemoto, R
Ito, K
INTERNAL MEDICINE, 2000, 39 (08) : 667 - 669

← 1 2 3 4 5 →